Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the united states II. Study of the intra- and interlaboratory dissemination of extended-spectrum β-lactamase-producing Enterobacteriaceae
- 31 December 1994
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 20 (4) , 203-208
- https://doi.org/10.1016/0732-8893(94)90004-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?Diagnostic Microbiology and Infectious Disease, 1994
- Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolateAntimicrobial Agents and Chemotherapy, 1994
- Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation CephalosporinsAnnals of Internal Medicine, 1993
- Identification of a novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniaeJournal of Antimicrobial Chemotherapy, 1993
- Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facilityAntimicrobial Agents and Chemotherapy, 1990
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1990
- Epidemiology of extended spectrum β-lactamasesInfection, 1989
- Broad-Spectrum, Transmissible β-LactamasesNew England Journal of Medicine, 1988
- Plasmid-Mediated Resistance to Third-Generation Cephalosporins Caused by Point Mutations in TEM-Type Penicillinase GenesClinical Infectious Diseases, 1988
- Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporinsJournal of Antimicrobial Chemotherapy, 1983